Genprex, Inc. - Common Stock (GNPX)
10.96
-0.54 (-4.70%)
NASDAQ · Last Trade: Oct 22nd, 7:17 PM EDT
Let's have a look at the gap up and gap down stocks in today's session.
Via Chartmill · October 22, 2025
Via Benzinga · October 22, 2025
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · October 20, 2025
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · October 17, 2025
Via Benzinga · October 17, 2025
In today's session, these stocks are experiencing unusual volume.
Via Chartmill · October 17, 2025
Via Benzinga · October 16, 2025
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via Chartmill · October 16, 2025
Via Benzinga · October 16, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · October 16, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · October 16, 2025
Via Benzinga · October 16, 2025
Via Benzinga · October 16, 2025
Via Benzinga · October 15, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · October 15, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the most active stocks in today's session.
Via Chartmill · October 15, 2025
Via Benzinga · October 15, 2025
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · October 15, 2025
Via Benzinga · October 15, 2025
Via Benzinga · October 15, 2025
Genprex shares jumped 41% in after-hours trading following news of a key cancer therapy presentation and ongoing research collaborations.
Via Benzinga · October 15, 2025
Via Benzinga · October 14, 2025
Via Benzinga · October 14, 2025